GSK’s asthma biologic hits quality of life goal

7th March 2017 Uncategorised 0

GlaxoSmithKline has presented new data showing that its asthma drug Nucala “significantly improves” quality of life and lung function in patients with a severe, eosinophilic form of the condition.

More: GSK’s asthma biologic hits quality of life goal
Source: News